HANNAH ROBINSON: Open Payments
NPI 1881317196 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 21 payments from 8 companies in 2025. Trend: 2023 $525 · 2024 $458 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $243 |
| Antares Pharma, Inc. | 5 | $78 |
| Noven Therapeutics, LLC | 2 | $46 |
| Tris Pharma Inc | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
Products named: BOTOX, UBRELVY, XYOSTED, Xelstrym, Dyanavel XR, AZMIRO, NURTEC ODT, QULIPTA.
Industry payments across GA — which companies pay providers there.
